TIM
RLMD icon

Tortoise Investment Management’s Relmada Therapeutics RLMD Stock Holding History

Tortoise Investment Management’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,909
Closed -$67.2K – 263
2025
Q4 		$67.2K Hold
13,909
– – 0.01% 237
2025
Q3 		$28K Sell
13,909
-7,767
-36% -$7.45K ﹤0.01% 470
2025
Q2 		$13K Hold
21,676
– – ﹤0.01% 569
2025
Q1 		$5.85K Hold
21,676
– – ﹤0.01% 622
2024
Q4 		$11.3K Hold
21,676
– – ﹤0.01% 616
2024
Q3 		$70.2K Hold
21,676
– – 0.01% 361
2024
Q2 		$65K Hold
21,676
– – 0.01% 356
2024
Q1 		$101K Hold
21,676
– – 0.01% 294
2023
Q4 		$89.7K Hold
21,676
– – 0.01% 291
2023
Q3 		$65K Buy
21,676
+2,500
+13% +$7.43K 0.01% 313
2023
Q2 		$47.2K Buy
19,176
+6,615
+53% +$18.3K 0.01% 354
2023
Q1 		$28.4K Buy
12,561
+4,976
+66% +$17.2K ﹤0.01% 409
2022
Q4 		$26.5K Buy
7,585
+2,300
+44% +$20.2K ﹤0.01% 412
2022
Q3 		$196K Sell
5,285
-796
-13% -$22.1K 0.04% 184
2022
Q2 		$115K Hold
6,081
– – 0.02% 214
2022
Q1 		$164K Sell
6,081
-600
-9% -$12.4K 0.03% 193
2021
Q4 		$151K Buy
6,681
+1,150
+21% +$25.6K 0.03% 187
2021
Q3 		$145K Buy
5,531
+1,196
+28% +$32K 0.03% 183
2021
Q2 		$139K Hold
4,335
– – 0.03% 181
2021
Q1 		$153K Hold
4,335
– – 0.03% 170
2020
Q4 		$139K Buy
4,335
+500
+13% +$17.2K 0.03% 169
2020
Q3 		$144K Hold
3,835
– – 0.04% 157
2020
Q2 		$172K Hold
3,835
– – 0.04% 145
2020
Q1 		$131K Buy
3,835
+935
+32% +$37.7K 0.04% 153
2019
Q4 		$113K Buy
+2,900
New +$88.1K 0.03% 180

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Tortoise Investment Management's RLMD Position: Q1 2026 in Review

Tortoise Investment Management sold out of Relmada Therapeutics (RLMD) in Q1 2026, closing a stake of 13,909 shares — an estimated $67.2K sold.

Tortoise Investment Management first reported a position in RLMD in Q4 2019 and held it in 25 quarters. The position peaked at $196K in Q3 2022. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Tortoise Investment Management reported no remaining Relmada Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tortoise Investment Management sold 13,909 Relmada Therapeutics shares in Q1 2026, an estimated $67.2K.
  • Tortoise Investment Management first reported a position in Relmada Therapeutics in Q4 2019 and held it in 25 quarters.
  • Tortoise Investment Management's Relmada Therapeutics position peaked at $196K in Q3 2022.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Tortoise Investment Management's 13F filing for Q1 2026, filed 5 May 2026.